These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 24662438

  • 1. Intracranial hemorrhage during dabigatran treatment.
    Komori M, Yasaka M, Kokuba K, Matsuoka H, Fujimoto S, Yoshida M, Kameda K, Shono T, Nagata S, Ago T, Kitazono T, Okada Y.
    Circ J; 2014; 78(6):1335-41. PubMed ID: 24662438
    [Abstract] [Full Text] [Related]

  • 2. Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.
    Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S.
    Stroke; 2012 Jun; 43(6):1511-7. PubMed ID: 22492518
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage.
    Aron JL, Gosselin R, Moll S, Arkin CF, Mantha S.
    J Thromb Thrombolysis; 2014 Jun; 37(2):76-9. PubMed ID: 23519385
    [No Abstract] [Full Text] [Related]

  • 4. Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.
    Vaughan Sarrazin MS, Jones M, Mazur A, Chrischilles E, Cram P.
    Am J Med; 2014 Dec; 127(12):1179-85. PubMed ID: 25107386
    [Abstract] [Full Text] [Related]

  • 5. New era of oral anticoagulation for Japanese non-valvular atrial fibrillation patients.
    Hirano T.
    Circ J; 2014 Dec; 78(6):1317-9. PubMed ID: 24805358
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ, Reichman ME, Wernecke M, Zhang R, Southworth MR, Levenson M, Sheu TC, Mott K, Goulding MR, Houstoun M, MaCurdy TE, Worrall C, Kelman JA.
    Circulation; 2015 Jan 13; 131(2):157-64. PubMed ID: 25359164
    [Abstract] [Full Text] [Related]

  • 7. Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature.
    Wassef SN, Abel TJ, Grossbach A, Viljoen SV, Jackson AW, Howard MA, Greenlee JD.
    Neurosurgery; 2013 Aug 13; 73(2):E368-73; discussion E373-4. PubMed ID: 23670031
    [Abstract] [Full Text] [Related]

  • 8. Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
    Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S.
    Circulation; 2013 Nov 19; 128(21):2325-32. PubMed ID: 24081972
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.
    Ross B, Miller MA, Ditch K, Tran M.
    J Med Toxicol; 2014 Jun 19; 10(2):223-8. PubMed ID: 24385325
    [Abstract] [Full Text] [Related]

  • 10. Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin.
    Alonso A, Bengtson LG, MacLehose RF, Lutsey PL, Chen LY, Lakshminarayan K.
    Stroke; 2014 Aug 19; 45(8):2286-91. PubMed ID: 24994722
    [Abstract] [Full Text] [Related]

  • 11. Dabigatran-induced acute hepatitis.
    Rochwerg B, Xenodemetropoulos T, Crowther M, Spyropoulos A.
    Clin Appl Thromb Hemost; 2012 Sep 19; 18(5):549-50. PubMed ID: 22962308
    [No Abstract] [Full Text] [Related]

  • 12. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
    Kawabata M, Yokoyama Y, Sasano T, Hachiya H, Tanaka Y, Yagishita A, Sugiyama K, Nakamura T, Suzuki M, Isobe M, Hirao K.
    J Cardiol; 2013 Aug 19; 62(2):121-6. PubMed ID: 23680005
    [Abstract] [Full Text] [Related]

  • 13. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Aug 19; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 14. Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study.
    Kosiuk J, Koutalas E, Doering M, Nedios S, Sommer P, Rolf S, Darma A, Breithardt OA, Dinov B, Hindricks G, Richter S, Bollmann A.
    Circ J; 2014 Aug 19; 78(10):2402-7. PubMed ID: 25253506
    [Abstract] [Full Text] [Related]

  • 15. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW, Ho MH, Chan PH, Hai JJ, Cheung E, Yeung CY, Lau KK, Chan KH, Lau CP, Lip GY, Leung GK, Tse HF, Siu CW.
    Stroke; 2015 Jan 19; 46(1):23-30. PubMed ID: 25406148
    [Abstract] [Full Text] [Related]

  • 16. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
    Eikelboom JW, Connolly SJ, Hart RG, Wallentin L, Reilly P, Oldgren J, Yang S, Yusuf S.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):900-8. PubMed ID: 23770182
    [Abstract] [Full Text] [Related]

  • 17. CHA2DS2-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough.
    Owada S, Tomita H, Kinjo T, Ishida Y, Itoh T, Sasaki K, Horiuchi D, Kimura M, Sasaki S, Okumura K.
    Thromb Res; 2015 Jan 03; 135(1):62-7. PubMed ID: 25466835
    [Abstract] [Full Text] [Related]

  • 18. Dabigatran and postmarketing reports of bleeding.
    Southworth MR, Reichman ME, Unger EF.
    N Engl J Med; 2013 Apr 04; 368(14):1272-4. PubMed ID: 23484796
    [No Abstract] [Full Text] [Related]

  • 19. Application of the RELY study to lifetime risks of atrial fibrillation: implications for spontaneous intracranial hemorrhage.
    Parry PV, Engh JA.
    Neurosurgery; 2012 Feb 04; 70(2):N10-1. PubMed ID: 22251978
    [No Abstract] [Full Text] [Related]

  • 20. Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.
    Larsen TB, Gorst-Rasmussen A, Rasmussen LH, Skjøth F, Rosenzweig M, Lip GY.
    Am J Med; 2014 Jul 04; 127(7):650-656.e5. PubMed ID: 24530792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.